Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration-Reference-Cited by-同舟云学术

Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration

Published:2011-04 Issue:2 Volume:151 Page:131-138
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Wen Ziyi,Yan Zhiqiang,Hu Kaili,Pang Zhiqing,Cheng Xufei,Guo LiangRan,Zhang Qizhi,Jiang Xinguo,Fang Liang,Lai Ren

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference33 articles.

1. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood–brain barrier;Kreuter;J. Drug Target.,2002

2. The blood–brain barrier: bottleneck in brain drug development;Pardridge;NeuroRx,2005

3. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease;Collister;Drug News Perspect.,2005

4. CNS gene therapy and a nexus of complexity: systems and biology at a crossroads;Tyler;Cell Transplant.,2006

5. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders;Kabanov;Prog. Polym. Sci.,2007

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing and Formulation of Nanocarriers for “Alzheimer’s and Parkinson’s” Early Detection and Therapy;CNS & Neurological Disorders - Drug Targets;2024-10

2. Rational Development of Fingolimod Nano-embedded Microparticles as Nose-to-Brain Neuroprotective Therapy for Ischemic Stroke;2024-08-19

3. Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides;ACS Nano;2024-08-12

4. Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach;Current Diabetes Reviews;2024-05-15

5. PLGA nanoparticles for nasal drug delivery;Journal of Drug Delivery Science and Technology;2024-05